Consolidated statement of comprehensive income |
Notes |
2025 |
2024 adjusted |
|---|---|---|---|
in EUR ‘000 |
|
|
|
Result for the period |
|
858,328 |
647,552 |
Other comprehensive income (OCI) |
10.4. |
143,296 |
13,844 |
Items that will not be reclassifiable to profit or loss in subsequent periods |
|
164,369 |
-24,965 |
Remeasurements of defined benefit plans |
|
54,619 |
-3,121 |
Share of other reserves of investments in associates |
|
146 |
179 |
Equity instruments designated measured at FVtOCI |
|
23,492 |
-1,845 |
Unrealised gains and losses acc. to IFRS 17 |
|
128,122 |
-36,678 |
Taxes |
|
-42,010 |
16,500 |
Items that will be reclassifiable to profit or loss in subsequent periods |
|
-21,073 |
38,809 |
Exchange rate changes through equity |
|
40,404 |
-17,396 |
Unrealised gains and losses from debt instruments measured at FVtOCI |
|
-54,954 |
173,910 |
Unrealised gains and losses acc. to IFRS 17 |
|
-33,808 |
-93,031 |
Share of other reserves of investments in associates |
|
1,303 |
3,732 |
Taxes |
|
25,982 |
-28,406 |
Comprehensive income for the period |
|
1,001,624 |
661,396 |
Attributable to shareholders and other stakeholders of the parent company |
|
973,677 |
641,373 |
Non-controlling interests |
|
27,947 |
20,023 |